high pharmacologic doses (1-3 g/day) can cause hypotension, insulin resistance, and hepatotoxicity
A growing number of patients with established migraine histories report that after the initial adjustment period, their migraines become less frequent and less severe
People using it should be monitored by a healthcare provider, since possible side effects and safety may vary
PubMed laboratory research record [PMID: 39041260] PubMed record related to this compound for laboratory literature review
There are few treatments available for this type of patient, and HFpEF is historically difficult to treat
Cost considerations for Mounjaro, especially without coverage paralleling weight management, make exploring alternatives like Zepbound or telehealth services through clinics essential